Scientists launched a National Institutes of Health-backed research study with countless university student to determine whether Moderna’s COVID vaccine can avoid asymptomatic spread of the infection.
Why it matters: The outcomes of the trial could provide immunized people insight on how cautious they really require to be when in close contact with others.
What they’re stating: ” This is a concern of extreme importance,” Anthony Fauci, director of the National Institute of Allergy and Infectious Illness, stated at a press instruction on Friday.
- ” But the prevailing concern is when these people get contaminated, how frequently is that? If they’re asymptomatic, how much virus do they have in their nose and do they transfer it to individuals who are their close contacts?” he added.
The state of play: The research study, which launched Thursday, is searching for 12,000 college students to volunteer across 21 campuses, including the University of Maryland, the University of North Carolina, Texas A&M and Indiana University.
- Trainees can sign up here, with multiple ways to get involved. “You can lastly fall asleep in class, not Zoom,” the site states.
- Half of the volunteers will be arbitrarily chosen to get Moderna’s vaccine immediately. The other half will receive their shots in approximately 4 months.
- Scientist will track the trainees by having them swab their noses and place the specimen in bar-coded vials for collection. Blood samples will be taken to test for antibodies and tracked through an app.
- Some trainee volunteers can earn money almost $1,000 to take part totally.
The bottom line: The results, which are expected in September, will equip the public and federal government with science-based proof on mask use and social distancing post-vaccination.
Comments
Post a Comment